Efficacy and Safety of Arotinolol Hydrochloride on Morning Blood Pressure and Heart Rate
Clinical trial NCT02612298 · COMPLETED
Trial details
- NCT number
- NCT02612298
- Sponsor
- Marubeni Pharmaceuticals (Suzhou) Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2018-09-13
- Enrollment
- 198
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.